{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:14:02Z","timestamp":1791526442523,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,7]],"date-time":"2008-12-07T00:00:00Z","timestamp":1228608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/nm.1893","type":"journal-article","created":{"date-parts":[[2008,12,7]],"date-time":"2008-12-07T19:13:16Z","timestamp":1228677196000},"page":"75-83","source":"Crossref","is-referenced-by-count":199,"title":["A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy"],"prefix":"10.1038","volume":"15","author":[{"given":"Kristina","family":"Lorenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim P","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M","family":"Schmitteckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,7]]},"reference":[{"key":"BFnm1893_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s001090050275","volume":"76","author":"PH Sugden","year":"1998","unstructured":"Sugden, P.H. & Clerk, A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76, 725\u2013746 (1998).","journal-title":"J. Mol. Med."},{"key":"BFnm1893_CR2","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nm1101-1236","volume":"7","author":"N Wettschureck","year":"2001","unstructured":"Wettschureck, N. et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of G\u03b1q\/G\u03b111 in cardiomyocytes. Nat. Med. 7, 1236\u20131240 (2001).","journal-title":"Nat. Med."},{"key":"BFnm1893_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0195-668X(02)00829-1","volume":"24","author":"DJ Lips","year":"2003","unstructured":"Lips, D.J., deWindt, L.J. & van Kraaij, D.J.W. & Doevendans, P.A. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur. Heart J. 24, 883\u2013896 (2003).","journal-title":"Eur. Heart J."},{"key":"BFnm1893_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tcm.2005.06.008","volume":"15","author":"AJ Muslin","year":"2005","unstructured":"Muslin, A.J. Role of Raf proteins in cardiac hypertrophy and cardiomyocyte survival. Trends Cardiovasc. Med. 15, 225\u2013229 (2005).","journal-title":"Trends Cardiovasc. Med."},{"key":"BFnm1893_CR5","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/01.RES.78.6.954","volume":"78","author":"PE Glennon","year":"1996","unstructured":"Glennon, P.E. et al. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ. Res. 78, 954\u2013961 (1996).","journal-title":"Circ. Res."},{"key":"BFnm1893_CR6","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","volume":"19","author":"OF Bueno","year":"2000","unstructured":"Bueno, O.F. et al. The MEK1\u2013ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19, 6341\u20136350 (2000).","journal-title":"EMBO J."},{"key":"BFnm1893_CR7","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1006\/jmcc.2001.1427","volume":"33","author":"Y Takeishi","year":"2001","unstructured":"Takeishi, Y. et al. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stress. J. Mol. Cell. Cardiol. 33, 1637\u20131648 (2001).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnm1893_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/01.CIR.103.5.670","volume":"103","author":"S Haq","year":"2001","unstructured":"Haq, S. et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103, 670\u2013677 (2001).","journal-title":"Circulation"},{"key":"BFnm1893_CR9","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1073\/pnas.0610906104","volume":"104","author":"NH Purcell","year":"2007","unstructured":"Purcell, N.H. et al. Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 104, 14074\u201314079 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1893_CR10","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1073\/pnas.89.13.5779","volume":"89","author":"AJ Rossomando","year":"1992","unstructured":"Rossomando, A.J. et al. Identification of Tyr-185 as the site of tyrosine autophosphorylation of recombinant mitogen-activated protein kinase p42mapk. Proc. Natl. Acad. Sci. USA 89, 5779\u20135783 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1893_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","volume":"9","author":"R Seger","year":"1995","unstructured":"Seger, R. & Krebs, E.G. The MAPK signalling cascade. FASEB J. 9, 726\u2013735 (1995).","journal-title":"FASEB J."},{"key":"BFnm1893_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1677\/jme.0.0300117","volume":"30","author":"LM Luttrell","year":"2003","unstructured":"Luttrell, L.M. 'Location, location, location': activation and targeting of MAP kinases by G protein\u2013coupled receptors. J. Mol. Endocrinol. 30, 117\u2013126 (2003).","journal-title":"J. Mol. Endocrinol."},{"key":"BFnm1893_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.tem.2006.07.008","volume":"17","author":"CJ Caunt","year":"2006","unstructured":"Caunt, C.J., Finch, A.R., Sedgley, K.R. & McArdle, C.A. Seven-transmembrane receptor signalling and ERK compartmentalization. Trends Endocrinol. Metab. 17, 276\u2013283 (2006).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnm1893_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/jb\/mvh159","volume":"136","author":"S Torii","year":"2004","unstructured":"Torii, S., Nakayama, K., Yamamoto, T. & Nishida, E. Regulatory mechanisms and function of ERK MAP kinases. J. Biochem. 136, 557\u2013561 (2004).","journal-title":"J. Biochem."},{"key":"BFnm1893_CR15","doi-asserted-by":"publisher","first-page":"6258","DOI":"10.1074\/jbc.M212231200","volume":"278","author":"A Tohgo","year":"2003","unstructured":"Tohgo, A. et al. The stability of the G protein\u2013coupled receptor\u2013\u03b2-arrestin interaction determines the mechanism and functional consequence of ERK activation. J. Biol. Chem. 278, 6258\u20136267 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1893_CR16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/369418a0","volume":"369","author":"P Crespo","year":"1994","unstructured":"Crespo, P., Xu, N., Simonds, W.F. & Gutkind, J.S. Ras-dependent activation of MAP kinase pathway mediated by G-protein \u03b2\u03b3 subunits. Nature 369, 418\u2013420 (1994).","journal-title":"Nature"},{"key":"BFnm1893_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0960-9822(99)80426-6","volume":"9","author":"JR Slupsky","year":"1999","unstructured":"Slupsky, J.R. et al. Binding of G\u03b2\u03b3 subunits to cRaf1 downregulates G protein-coupled receptor signalling. Curr. Biol. 9, 971\u2013974 (1999).","journal-title":"Curr. Biol."},{"key":"BFnm1893_CR18","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.1016\/S0021-9258(17)37127-2","volume":"269","author":"M Faure","year":"1994","unstructured":"Faure, M., Voyno-Yasenetskaya, T.A. & Bourne, H.R. cAMP and \u03b2\u03b3 subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem. 269, 7851\u20137854 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnm1893_CR19","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/sj.onc.1204181","volume":"20","author":"WF Schwindinger","year":"2001","unstructured":"Schwindinger, W.F. & Robishaw, J.D. Heterotrimeric G protein \u03b2\u03b3 dimers in growth and differentiation. Oncogene 20, 1653\u20131660 (2001).","journal-title":"Oncogene"},{"key":"BFnm1893_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/01.CIR.0000142291.70954.DF","volume":"111","author":"H Tachibana","year":"2005","unstructured":"Tachibana, H., Naga Prasad, S.V., Lefkowitz, R.J., Koch, W.J. & Rockman, H.A. Level of \u03b2-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure. Circulation 111, 591\u2013597 (2005).","journal-title":"Circulation"},{"key":"BFnm1893_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/sj.gt.3301995","volume":"10","author":"Z Li","year":"2003","unstructured":"Li, Z. et al. Effects of two G\u03b2\u03b3-binding proteins\u2014N-terminally truncated phosducin and \u03b2-adrenergic receptor kinase C terminus (\u03b2ARKct)\u2014in heart failure. Gene Ther. 10, 1354\u20131361 (2003).","journal-title":"Gene Ther."},{"key":"BFnm1893_CR22","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1126\/science.8052857","volume":"265","author":"SJ Mansour","year":"1994","unstructured":"Mansour, S.J. et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966\u2013970 (1994).","journal-title":"Science"},{"key":"BFnm1893_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1161\/01.CIR.0000086469.85750.48","volume":"108","author":"JP Schmitt","year":"2003","unstructured":"Schmitt, J.P. et al. Consequences of pressure overload on sarcomere protein mutation\u2013induced hypertrophic cardiomyopathy. Circulation 108, 1133\u20131138 (2003).","journal-title":"Circulation"},{"key":"BFnm1893_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/hh0202.104109","volume":"90","author":"WG Thomas","year":"2002","unstructured":"Thomas, W.G. et al. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ. Res. 90, 135\u2013142 (2002).","journal-title":"Circ. Res."},{"key":"BFnm1893_CR25","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0024-3205(97)00050-7","volume":"60","author":"JH Brown","year":"1997","unstructured":"Brown, J.H. et al. Pathways and roadblocks in muscarinic receptor\u2013mediated growth regulation. Life Sci. 60, 1077\u20131084 (1997).","journal-title":"Life Sci."},{"key":"BFnm1893_CR26","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1161\/01.CIR.97.15.1488","volume":"97","author":"Y Sakata","year":"1998","unstructured":"Sakata, Y., Hoit, B.D., Liggett, S.B., Walsh, R.A. & Dorn, G.W. II. Decompensation of pressure-overload hypertrophy in G\u03b1q-overexpressing mice. Circulation 97, 1488\u20131495 (1998).","journal-title":"Circulation"},{"key":"BFnm1893_CR27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1126\/science.280.5363.574","volume":"280","author":"SA Akhter","year":"1998","unstructured":"Akhter, S.A. et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280, 574\u2013577 (1998).","journal-title":"Science"},{"key":"BFnm1893_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/01.CIR.100.4.407","volume":"100","author":"S Rohrbach","year":"1999","unstructured":"Rohrbach, S. et al. Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors. Circulation 100, 407\u2013412 (1999).","journal-title":"Circulation"},{"key":"BFnm1893_CR29","first-page":"H2026","volume":"277","author":"RR Baliga","year":"1999","unstructured":"Baliga, R.R. et al. NRG-1\u2013induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am. J. Physiol. 277, H2026\u2013H2037 (1999).","journal-title":"Am. J. Physiol."},{"key":"BFnm1893_CR30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nature02158","volume":"426","author":"K Lorenz","year":"2003","unstructured":"Lorenz, K., Lohse, M.J. & Quitterer, U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426, 574\u2013579 (2003).","journal-title":"Nature"},{"key":"BFnm1893_CR31","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1126\/science.276.5320.1878","volume":"276","author":"H Umemori","year":"1997","unstructured":"Umemori, H. et al. Activation of the G protein Gq\/11 through tyrosine phosphorylation of the \u03b1 subunit. Science 276, 1878\u20131881 (1997).","journal-title":"Science"},{"key":"BFnm1893_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1124\/mol.107.044750","volume":"74","author":"J Luo","year":"2008","unstructured":"Luo, J., Busillo, J.M. & Benovic, J.L. M3 muscarinic acetylcholine receptor\u2013mediated signaling is regulated by distinct mechanisms. Mol. Pharmacol. 74, 338\u2013347 (2008).","journal-title":"Mol. Pharmacol."},{"key":"BFnm1893_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0092-8674(00)81189-7","volume":"93","author":"AV Khokhlatchev","year":"1998","unstructured":"Khokhlatchev, A.V. et al. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93, 605\u2013615 (1998).","journal-title":"Cell"},{"key":"BFnm1893_CR34","first-page":"2195","volume":"59","author":"J Hartkamp","year":"1999","unstructured":"Hartkamp, J., Troppmair, J. & Rapp, U.R. The JNK\/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion. Cancer. Res. 59, 2195\u20132202 (1999).","journal-title":"Cancer. Res."},{"key":"BFnm1893_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/1357-2725(95)00142-5","volume":"28","author":"MA Bogoyevitch","year":"1996","unstructured":"Bogoyevitch, M.A. & Sudgen, P.H. The role of protein kinases in adaptational growth of the heart. Int. J. Biochem. Cell. Biol. 28, 1\u201312 (1996).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"BFnm1893_CR36","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/01.RES.0000038488.38975.1A","volume":"91","author":"OF Bueno","year":"2002","unstructured":"Bueno, O.F. & Molkentin, J.D. Involvement of extracellular signal\u2013regulated kinases 1\/2 in cardiac hypertrophy and cell death. Circ. Res. 91, 776\u2013781 (2002).","journal-title":"Circ. Res."},{"key":"BFnm1893_CR37","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1038\/sj.emboj.7601252","volume":"25","author":"W Zhong","year":"2006","unstructured":"Zhong, W. et al. Hypertrophic growth in cardiac myocytes is mediated by Myc through a cyclin D2\u2013dependent pathway. EMBO J. 25, 3869\u20133879 (2006).","journal-title":"EMBO J."},{"key":"BFnm1893_CR38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.yjmcc.2004.08.002","volume":"37","author":"T Markou","year":"2004","unstructured":"Markou, T., Hadzopoulou-Cladarasb, M. & Lazou, A. Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways. J. Mol. Cell. Cardiol. 37, 1001\u20131011 (2004).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnm1893_CR39","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1006\/jmcc.2002.2014","volume":"34","author":"DM Valks","year":"2002","unstructured":"Valks, D.M. et al. Phenylephrine promotes phosphorylation of Bad in cardiac myocytes through the extracellular signal\u2013regulated kinases 1\/2 and protein kinase A. J. Mol. Cell. Cardiol. 34, 749\u2013763 (2002).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnm1893_CR40","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1172\/JCI24178","volume":"115","author":"GW Dorn II","year":"2005","unstructured":"Dorn, G.W. II & Force, T. Protein kinase cascades in regulation of cardiac hypertrophy. J. Clin. Invest. 115, 527\u2013537 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnm1893_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0955-0674(99)80028-3","volume":"11","author":"TP Garrington","year":"1999","unstructured":"Garrington, T.P. & Johnson, G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11, 211\u2013218 (1999).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnm1893_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37\u201340 (2001).","journal-title":"Nature"},{"key":"BFnm1893_CR43","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0006-2952(02)01135-8","volume":"64","author":"J Pouyss\u00e9gur","year":"2002","unstructured":"Pouyss\u00e9gur, J., Volmat, V. & Lenormand, P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem. Pharmacol. 64, 755\u2013763 (2002).","journal-title":"Biochem. Pharmacol."},{"key":"BFnm1893_CR44","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/emboj\/18.3.664","volume":"18","author":"A Brunet","year":"1999","unstructured":"Brunet, A. et al. Nuclear translocation of p42\/p44 mitogen-activated protein kinase is required for growth factor\u2013induced gene expression and cell cycle entry. EMBO J. 18, 664\u2013674 (1999).","journal-title":"EMBO J."},{"key":"BFnm1893_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0968-0004(99)01508-X","volume":"25","author":"MH Cobb","year":"2000","unstructured":"Cobb, M.H. & Goldsmith, E.J. Dimerization in MAP kinase signaling. Trends Biochem. Sci. 25, 7\u20139 (2000).","journal-title":"Trends Biochem. Sci."},{"key":"BFnm1893_CR46","doi-asserted-by":"publisher","first-page":"10439","DOI":"10.1073\/pnas.90.22.10439","volume":"90","author":"S M\u00fcller","year":"1993","unstructured":"M\u00fcller, S., Heckman, M. & Lohse, M.J. Specific enhancement of \u03b2-adrenergic receptor kinase activity by defined G\u03b2 and G\u03b3 subunits. Proc. Natl. Acad. Sci. USA 90, 10439\u201310443 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1893_CR47","doi-asserted-by":"publisher","first-page":"24584","DOI":"10.1074\/jbc.M414630200","volume":"280","author":"M Frank","year":"2005","unstructured":"Frank, M., Th\u00fcmer, L., Lohse, M.J. & B\u00fcnemann, M. G protein activation without subunit dissociation depends on G\u03b1i-specific region. J. Biol. Chem. 280, 24584\u201324590 (2005).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.1893.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1893","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1893.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:22:56Z","timestamp":1684448576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.1893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFnm1893"],"URL":"https:\/\/doi.org\/10.1038\/nm.1893","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,7]]}}}